Methotrexate (2.5 mg)

admin — Wed, 18 Feb 2026 10:55:01 +0000

Overview: Zydus Imat 400 mg Tablet is a prescription anticancer medicine containing Imatinib Mesylate (400 mg), belonging to the class of tyrosine kinase inhibitors. It is used to treat specific cancers by targeting abnormal proteins involved in cancer cell growth and division. Key Benefits: – Effective in managing chronic myeloid leukaemia (CML) – Helps control progression of gastrointestinal stromal tumors (GIST) – Oral therapy with once-daily dosing – Widely prescribed by oncologists for targeted cancer treatment Composition: Imatinib Mesylate (400 mg) How It Works: Imatinib blocks the activity of BCR-ABL and other tyrosine kinases, which are proteins that promote the growth and spread of cancer cells. This targeted action slows tumor progression and reduces cancer cell proliferation. Usage Instructions: – Take exactly as prescribed by your healthcare provider – Swallow the tablet whole with water, with or without food – Do not chew or crush the tablet Side Effects: – Nausea, vomiting, diarrhea, headache, fatigue – Fluid retention, edema, muscle cramps – Rash, abdominal pain, loss of appetite Precautions: – Not recommended during pregnancy or breastfeeding – use effective contraception during treatment :contentReference[oaicite:0]{index=0} – Inform your doctor about all medications you are taking to avoid interactions – Regular monitoring of blood counts and liver function is advised Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and direct sunlight Manufacturer: Zydus Cadila Life Sciences Ltd Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.

anti cancer medicine – Globalstar International

Methotrexate (2.5 mg)